What are you looking for?
Need help finding what you are looking for? Contact Us

PUBLISHER: Ken Research Private Limited | PRODUCT CODE: 1337556

Cover Image

PUBLISHER: Ken Research Private Limited | PRODUCT CODE: 1337556

India POC Immunoassay Analyzers Market

DELIVERY TIME: 1-2 business days
Online Access Excel (Single User License)
USD 3500
Online Access PDF (Single User License)
USD 4750
Online Access PDF & Excel (Corporate User License)
USD 9000

Add to Cart

Country Overview:

India is one of the fastest-growing economies in the world, and this growth extends to its healthcare sector as well. The country had been steadily expanding its healthcare infrastructure and capabilities, particularly in response to the COVID-19 pandemic.

Point-of-care testing (POCT), including the use of immunoassay analyzers, had been increasing in demand due to the need for rapid, accurate testing in a variety of settings. These devices are used to detect and quantify specific analytes in blood or other body fluids, aiding in diagnosing and managing diseases.

Given the vast population of India and the considerable challenges in reaching rural and remote communities, point-of-care testing has significant potential. These analyzers allow for decentralized healthcare, bringing diagnostics closer to the patient and enabling faster decision-making. The immunoassay analyzer market has been seeing significant growth in India from past 5 years.

Companies mentioned in the India POC Immunoassays Analyzer Competition benchmarking are - Quidel, BioMerieux, Getein Biotech, Boditech and SD Biosensors. All these companies have a strong presence in the Indian POC immunoassay analyzers market, each offering a unique mix of advantages in terms of product range, turnaround time, ease of maintenance, and cost.

India POC Immunoassay Analyzers Competition Benchmarking Analysis

Players like Quidel, BioMerieux, Getein Biotech, Boditech, and SD Biosensors offering a wide range of analyzers. These analyzers provide various testing options, including cardiac markers, infection marker testing, and coagulation testing.

Turnaround times vary among the different analyzers, with some offering quick results in minutes. The level of automation also varies, with some analyzers being fully automated, while others are semi-automated or manual.

One key factor for healthcare facilities to consider is the cost, as it can vary significantly between analyzers and tests.

Quidel, BioMerieux, Getein Biotech, Boditech, and SD Biosensors each have their strengths and unique offerings, allowing healthcare facilities to choose the best fit for their specific needs.

Key Trends by Market Segment:

By Hospital ICU Bed Capacity: Boditech acquired the most dominant player in the Hospital ICU Bed Capacity segment in 2021 in India POC immunoassay analyzers sector, capturing maximum hospitals having maximum capacity of 20 ICU beds or less.

By Testing Volume: Boditech has the maximum testing volume compared to other companies, having the major portion of testing volume in the range of 100 - 300 test per month in 2021.

Boditech's captured a major portion of the testing volume due to its extensive testing menu and the ability to cater to a wide range of medical parameters. With analyzers like the Standard and MultiCare offering, including cardiac markers, infection markers, and more, Boditech's products appealed to diverse healthcare facilities, including hospitals, clinics, and diagnostic centers.

Recent Developments:

In February 2022, Boditech Med and SphingoTec Close Global Licensing Agreement for Kidney Function Biomarker Proenkephalin A 119-159 (penKid).

In April 2023, JMI Laboratories and bioMerieux announced Antimicrobial Resistance Diagnostics Partnership. They announced that they together will work to improve and develop microbiology diagnostic tools.

Product Code: KR1365

Table Of Contents

1. Executive Summary

2. Quidel Market Sheet

  • 2.1 Quidel Market Size Basis Installed Base, 2021-2022
  • 2.2 Quidel Market Segmentation
  • 2.3 Quidel Market Positioning
  • 2.4 Quidel Testing Menu
  • 2.5 List of Hospitals

3. BioMerieux Market Sheet

  • 3.1 bioMerieux Market Size Basis Installed Base, 2021-2022
  • 3.2 bioMerieux Market Segmentation
  • 3.3 bioMerieux Market Positioning
  • 3.4 Testing Menu
  • 3.5 List of Hospitals

4. Getein Biotech Market Sheet

  • 4.1 Getein Biotech Market Size Basis Installed Base, 2021-2022
  • 4.2 Getein Biotech Market Segmentation
  • 4.3 Getein Biotech Market Positioning
  • 4.4 Testing Menu
  • 4.5 List of Hospitals

5. Boditech Market Sheet

  • 5.1 Boditech Market Size Basis Installed Base, 2021-2022
  • 5.2 Boditech Market Segmentation
  • 5.3 Boditech Market Positioning
  • 5.4 Testing Menu
  • 5.5 List of Hospitals

6. SD Biosensor Market Sheet

  • 6.1 SD Biosensor Market Size Basis Installed Base, 2021-2022
  • 6.2 SD Biosensor Market Segmentation
  • 6.3 SD Biosensor Market Positioning

7.Testing Menu

  • 7.1 List of Hospitals

8. Competition Sheet

  • 8.1 Market Dynamics (Product, Portfolio, Quick TAT, Ease of Maintenance & Inventory,
  • 8.2 Manual VS semi-automated vs Fully automated, Cost of Device and Cost per test)
  • 8.3 SWOT Analysis

9. Research Methodology

  • 9.1 Market Definitions and Assumptions and Abbreviations
  • 9.2 Consolidated Research Approach
  • 9.3 Primary Research Approach
  • 9.4 Limitation and Future Conclusion

10. Disclaimer

11. Contact Us

Have a question?

Jeroen Van Heghe

Manager - EMEA



Christine Sirois

Manager - Americas


Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!